How Can Omic Science be Improved?

Simons, Kai

doi:10.1002/pmic.201800039

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

How Can Omic Science be Improved?

MPS-Authors

/cone/persons/resource/persons219671

Simons, Kai
Max Planck Institute for Molecular Cell Biology and Genetics, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Simons, K. (2018). How Can Omic Science be Improved? Proteomics, 18(5-6): e1800039. doi:10.1002/pmic.201800039.

Cite as: https://hdl.handle.net/21.11116/0000-0003-F68C-A

Abstract

One of the promises of multiomic analysis was to transform the clinical diagnostics to deliver much more exact phenotyping of disease states. However, despite enormous investments, the transformation of clinical routine has not taken place. There are many reasons for this lack of success but one is the failure to deliver quantitative and reproducible data. This failure is not only impeding progress in clinical phenotyping but also in the application of omic science in systems biology. The focus in this Viewpoint will be on lipidomics but the lessons learned are generally applicable.